Title |
11β-Hydroxysteroid Dehydrogenase Type 1 Gene Knockout Attenuates Atherosclerosis and In Vivo Foam Cell Formation in Hyperlipidemic apoE−/− Mice
|
---|---|
Published in |
PLOS ONE, February 2013
|
DOI | 10.1371/journal.pone.0053192 |
Pubmed ID | |
Authors |
Ricardo A. García, Debra J. Search, John A. Lupisella, Jacek Ostrowski, Bo Guan, Jian Chen, Wen-Pin Yang, Amy Truong, Aiqing He, Rongan Zhang, Mujing Yan, Samuel E. Hellings, Peter S. Gargalovic, Carol S. Ryan, Linda M. Watson, Robert A. Langish, Petia A. Shipkova, Nancy L. Carson, Joseph R. Taylor, Richard Yang, George C. Psaltis, Thomas W. Harrity, Jeffrey A. Robl, David A. Gordon |
Abstract |
Chronic glucocorticoid excess has been linked to increased atherosclerosis and general cardiovascular risk in humans. The enzyme 11β-hydroxysteroid dehydrogenase type 1 (11βHSD1) increases active glucocorticoid levels within tissues by catalyzing the conversion of cortisone to cortisol. Pharmacological inhibition of 11βHSD1 has been shown to reduce atherosclerosis in murine models. However, the cellular and molecular details for this effect have not been elucidated. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Indonesia | 1 | 2% |
Spain | 1 | 2% |
Netherlands | 1 | 2% |
Belgium | 1 | 2% |
Unknown | 43 | 91% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 9 | 19% |
Researcher | 6 | 13% |
Student > Bachelor | 6 | 13% |
Professor > Associate Professor | 5 | 11% |
Student > Doctoral Student | 4 | 9% |
Other | 8 | 17% |
Unknown | 9 | 19% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 12 | 26% |
Medicine and Dentistry | 11 | 23% |
Pharmacology, Toxicology and Pharmaceutical Science | 4 | 9% |
Biochemistry, Genetics and Molecular Biology | 3 | 6% |
Psychology | 2 | 4% |
Other | 3 | 6% |
Unknown | 12 | 26% |